ZUG, Switzerland--(BUSINESS WIRE)--Galderma today announced that it will present new data from the ARCADIA and OLYMPIA clinical trial programs investigating nemolizumab in atopic dermatitis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback